Access cutting-edge lung cancer treatment through this clinical trial at a research site in Golden. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Golden at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed by pembrolizumab with or without maintenance sacituzumab tirumotecan (sac-TMT; MK-2870) in first-line treatment of metastatic squamous non-small cell lung cancer. It is hypothesized that pembrolizumab with maintenance sacituzumab tirumotecan is superior to pembrolizumab without sacituzumab tirumotecan maintenance with respect to overall survival (OS).
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this lung cancer clinical trial in Golden, CO
If you're searching for lung cancer treatment options in Golden, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Golden research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.